TONIX PHARMACEUTICALS HLDG C's ticker is TNXP and the CUSIP is 890260201. A total of 49 filers reported holding TONIX PHARMACEUTICALS HLDG C in Q3 2015. The put-call ratio across all filers is 2.52 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $302,000 | -7.6% | 64,645 | -90.7% | 0.02% | +6.2% |
| Q4 2016 | $327,000 | -61.8% | 696,455 | -43.3% | 0.02% | -59.0% |
| Q3 2016 | $856,000 | -79.5% | 1,227,832 | -41.5% | 0.04% | -83.0% |
| Q2 2016 | $4,174,000 | +11.9% | 2,097,248 | +35.5% | 0.23% | +12.2% |
| Q1 2016 | $3,729,000 | -66.9% | 1,547,248 | +5.4% | 0.20% | -62.5% |
| Q4 2015 | $11,258,000 | +77.9% | 1,467,858 | +22.7% | 0.55% | +79.3% |
| Q3 2015 | $6,328,000 | -21.7% | 1,196,202 | +32.7% | 0.30% | -3.5% |
| Q2 2015 | $8,084,000 | +45.2% | 901,202 | +2.3% | 0.32% | +33.9% |
| Q1 2015 | $5,569,000 | +65.8% | 881,202 | +53.3% | 0.24% | +61.6% |
| Q4 2014 | $3,358,000 | -5.9% | 575,000 | +9.5% | 0.15% | -8.8% |
| Q3 2014 | $3,570,000 | -9.3% | 525,000 | +90.9% | 0.16% | +6.0% |
| Q2 2014 | $3,938,000 | +37.7% | 275,000 | 0.0% | 0.15% | +3.4% |
| Q1 2014 | $2,860,000 | – | 275,000 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 565,000 | $4,334,000 | 1.81% |
| Ghost Tree Capital, LLC | 350,000 | $2,685,000 | 1.10% |
| Avoro Capital Advisors LLC | 340,300 | $2,610,000 | 0.90% |
| PURA VIDA INVESTMENTS, LLC | 217,900 | $1,671,000 | 0.70% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,467,858 | $11,258,000 | 0.55% |
| Broadfin Capital, LLC | 890,748 | $6,832,000 | 0.42% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,315,551 | $10,090,000 | 0.41% |
| Lombard Odier Asset Management (USA) Corp | 348,641 | $2,674,000 | 0.26% |
| TURNER INVESTMENTS LLC | 122,000 | $936,000 | 0.19% |
| Integre Asset Management, LLC | 64,317 | $493,000 | 0.12% |